Zai Lab (Hong Kong), Ltd. clinical trials
A country office of Zai Lab Limited
The registry lists 4 studies whose lead sponsor is Zai Lab (Hong Kong), Ltd.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 10, 2026.
Registry sponsor names on this page
- Zai Lab (Hong Kong), Ltd.4 studies
Something wrong with this grouping? Tell us on the Zai Lab Limited page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Zai Lab Limited studies →
- A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABPRecruitingNCT06162286Phase 3
Sponsor listed in the registry: Zai Lab (Hong Kong), Ltd.
- A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque PsoriasisTerminatedNCT06380907Phase 2
Sponsor listed in the registry: Zai Lab (Hong Kong), Ltd.
- A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid TumorsTerminatedNCT05859464Phase 1
Sponsor listed in the registry: Zai Lab (Hong Kong), Ltd.
- A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult VolunteersCompletedNCT06462326Phase 1
Sponsor listed in the registry: Zai Lab (Hong Kong), Ltd.